Cargando…
Repurposing Dipyridamole in Niemann Pick Type C Disease: A Proof of Concept Study
Niemann Pick type C disease (NPC) is a rare disorder characterized by lysosomal lipid accumulation that damages peripheral organs and the central nervous system. Currently, only miglustat is authorized for NPC treatment in Europe, and thus the identification of new therapies is necessary. The hypoth...
Autores principales: | Pepponi, Rita, De Simone, Roberta, De Nuccio, Chiara, Visentin, Sergio, Matteucci, Andrea, Bernardo, Antonietta, Popoli, Patrizia, Ferrante, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999038/ https://www.ncbi.nlm.nih.gov/pubmed/35408815 http://dx.doi.org/10.3390/ijms23073456 |
Ejemplares similares
-
Adenosine A(2A) receptor stimulation restores cell functions and differentiation in Niemann-Pick type C-like oligodendrocytes
por: De Nuccio, Chiara, et al.
Publicado: (2019) -
Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives
por: Bernardo, Antonietta, et al.
Publicado: (2021) -
Niemann–Pick type C disease as proof‐of‐concept for intelligent biomarker panel selection in neurometabolic disorders
por: Papandreou, Apostolos, et al.
Publicado: (2022) -
Insight into the Role of the STriatal-Enriched Protein Tyrosine Phosphatase (STEP) in A(2A) Receptor-Mediated Effects in the Central Nervous System
por: Domenici, Maria Rosaria, et al.
Publicado: (2021) -
Niemann-Pick disease type C
por: Vanier, Marie T
Publicado: (2010)